(Q34619565)

3 August 2017

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease (English)

1 reference

3 August 2017

0 references

0 references

1 reference

M Guttman

1

1 reference

3 August 2017

I Boileau

2

1 reference

3 August 2017

J Warsh

3

1 reference

3 August 2017

J A Saint-Cyr

4

1 reference

3 August 2017

N Ginovart

5

1 reference

3 August 2017

T McCluskey

6

1 reference

3 August 2017

S Houle

7

1 reference

3 August 2017

A Wilson

8

1 reference

3 August 2017

E Mundo

9

1 reference

3 August 2017

P Rusjan

10

1 reference

3 August 2017

J Meyer

11

1 reference

3 August 2017

S J Kish

12

1 reference

3 August 2017

language of work or name

1 reference

1 May 2007

1 reference

European Journal of Neurology

3 August 2017

1 reference

3 August 2017

14

1 reference

3 August 2017

5

1 reference

3 August 2017

523-528

1 reference

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Positron emission tomography of striatal serotonin transporters in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Effects of tryptophan depletion on the serotonin transporter in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

A review of the receptor-binding and pharmacokinetic properties of dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01727.X

10.1111/J.1468-1331.2007.01727.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference